Drug overdose deaths in the U.S. fell sharply in 2024, with new government data showing the steepest year-over-year decline in five years. Provisional figures released by the Centers for Disease ...
Legalized cannabis, a kinder attitude toward substance abuse and a shortage of workers has all added up to change the demand for drug testing over the past few years. A lot of companies have stopped ...
The Centers for Medicare & Medicaid Services on Friday rejected a Biden administration proposal to expand Medicare coverage of weight-loss drugs such as Eli Lilly's Zepbound and Novo Nordisk's Wegovy.
Medical and nonmedical use of prescription drugs, as well as peer-to-peer diversion, decreased significantly among adolescents in the United States between 2009 and 2022, a new study showed, with ...
It's the million-dollar question for law enforcement and prison officials: How to stop drugs from being smuggled into prisons? Contraband, including drugs, still comes into Ohio prisons via the ...
When Zepbound, Eli Lilly's highly anticipated weight loss drug, hit the market a year and a half ago, it marked a turning point for the accessibility of weight loss drugs. Since then, Zepbound, the ...
An employee from a healthcare giant at Donald Trump's drug pricing event in the Oval Office collapsed on Thursday. The man, whom the White House has refused to identify, fainted just feet away from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results